Brand names are Wegovy, Ozempic, and Rybelsus. Wegovy and Ozempic are injections taken once weekly, and Rybelsus is a tablet taken once daily.

Semaglutide for weight loss is a subcutaneous injection given once a week at home or sublingual (under the tongue) daily or every other day.

You may experience nausea, vomiting, diarrhea, abdominal pain, and constipation. Other less common side effects include elevated heart rate, allergic reactions, low blood sugar, pancreatitis, thyroid tumors, and kidney problems. If you have a history of medullary thyroid cancer and heart disease, this is not the medication for you.

Dosages are based on health conditions and your response to the treatments. It is started at a low dose and gradually increase your intake. Follow your provider’s instructions. Semaglutide for weight loss is typically used for 3- 6 months.

Tirzepatide is an injectable prescription medicine that is used along with diet and exercise to improve blood sugar (glucose) in adults with type 2 diabetes mellitus.

Brand name for tirzepatide is Mounjaro and Zepbound

Inflammation of the pancreas, low blood sugar, allergic reactions including swelling of your face, lips, tongue or throat, problems breathing or swallowing, severe rash or itching, fainting or feeling dizzy, and very rapid heartbeat, kidney problems, vision problems. The most common side effects of tirzepatide include nausea, diarrhea, decreased appetite, vomiting, constipation, indigestion, and stomach (abdominal) pain. Do not use tirzepatide if you or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC). Do not use tirzepatide if you have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) or are allergic to it or any of the ingredients in Mounjaro.

Birth control pills may not work as well while using tirzepatide. You can switch to a different birth control method, like the IUD, implant, or ring. You can use a backup method of birth control (like condoms) for 4 weeks when you start tirzepatide, and then again each time you increase your dose.

Tirzepatide is injected under the skin (subcutaneously) of your stomach (abdomen), thigh, or upper arm. Change your injection site weekly.

Both drugs are FDA approved in various brand names as treatments for type 2 diabetes and long-term weight loss. Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist and mimics the natural GLP-1 hormone in our bodies. It binds to the GLP-1 receptor to exert its effect.
Tirzepatide is a dual-acting glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist and binds to both GIP and GLP-1 receptors. Like GLP-1, GIP is also a natural incretin hormone and may increase the action of tirzepatide.
These medicines work by:
• stimulating insulin release from the pancreas when needed to help lower your blood sugar
• decreasing the amount of sugar made by your liver by suppressing glucagon secretion
• slowing the movement of food through your stomach (gastric emptying) which can help you feel fuller for a longer period of time, decrease your appetite and lead to weight loss.
These medicines should not be used together or with any other GLP-1 or GIP receptor agonists.

Yes. There are many other medications available for weight loss… Medications such as Contrave, Saxenda, Xenical, Plenity, Phentermine, Bupropion/Naltrexone are available. Speak to your provider to determine what is the best option for you to achieve your weight loss goal.

Yes. Lab work is required prior to the start of and during treatment.

Yes. With an action plan that will be tailored to your needs and lifestyle, we can achieve sustainable weight loss to reach your goal.

After 8 to 12 weeks people using tirzepatide (the active ingredient in Mounjaro) lost about 6% to 8% of their body weight on average using injection doses of 5, 10 or 15 mg per week.

You have not given the medicine enough time to work. Studies have shown that it can take 6 to 8 weeks to see up to an 8% weight loss with these medicines. While most people will see at least a 5% weight loss, not everyone will reach this goal. The research found that 89% of lost 5% or more of their weight at 72 weeks.